Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'mutant idh1 inhibitor'

Search results for: 'mutant idh1 inhibitor'

Items 31-40 of 68

Page
per page
  1. TAI-1
    B4892 TAI-1
    Target: Hec1
    Summary: Hec1 inhibitor, potent, first-in-class
      ≥43.2 mg/mL
  2. BML-277
    B1236 BML-277
    Target: Chk
    Summary: Chk2 inhibitor,potent and highly selective
      insoluble in H2O; ≥18.2 mg/mL
  3. ETP-46464
    A8626 ETP-46464
    Target: PI3K|mTOR|DNA-PK|ATM/ATR
    Summary: ATR inhibitor,potent and selective
      ≥16.13 mg/mL
  4. Flavopiridol
    A3417 Flavopiridol
    Target: Cyclin-Dependent Kinases
    Summary: Pan-cdk inhibitor
      insoluble in H2O; ≥40.2 mg/mL
  5. Dinaciclib (SCH727965)
    A8412 Dinaciclib (SCH727965)
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Potent CDK inhibitor
  6. NMS-1286937
    B4094 NMS-1286937
    Target: PLK
    Summary: PLK1 inhibitor, orally bioavailable
      insoluble in H2O; insoluble in EtOH; ≥13.33 mg/mL
  7. BI 2536
    A3965 BI 2536
     1 Citation
    Target: PLK|Bromodomain-containing proteins(BRDs)
    Summary: Plk1 inhibitor,potent and ATP-competitive
      insoluble in H2O; ≥13.04 mg/mL
  8. TC-A 2317 hydrochloride
    A4489 TC-A 2317 hydrochloride
    Target: Aurora Kinases
    Summary: Aurora kinase A inhibitor,potent and selective
      <39.29 mg/mL
  9. AZ20
    A3210 AZ20
     1 Citation
    Target: ATM/ATR
    Summary: ATR inhibitor,potent and selective
      ≥20.65 mg/mL
  10. R547
    A8642 R547
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK1/2/4 inhibitor,ATP-competitive
      Soluble in DMSO

Items 31-40 of 68

Page
per page
Shop By
Now Shopping by
  1. Category Cell Cycle/Checkpoint Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. ATM/ATR 4item
  2. Aurora Kinase 17item
  3. Cdc42 1 item
  4. Cdc7 1 item
  5. Chk 4item
  6. CRM1 1 item
  7. Cyclin-Dependent Kinases 18item
  8. E1 enzyme 1 item
  9. Ksp 1 item
  10. Microtubule/Tubulin 3item
  11. RAD51 1 item
  12. ROCK 5item
  13. Rho 2item
  14. PERK 1 item
  15. PLK 8item
  16. PTEN 1 item
Specificity
  1. Selective 38item
Reversibility
  1. Reversible 4item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 20item
  2. PI3K 1 item
  3. Aurora Kinases 16item
  4. mTOR 1 item
  5. FLT3 5item
  6. GSK-3 1 item
  7. PLK 9item
  8. Chk 4item
  9. VEGFR 1 item
  10. PDGFR 1 item
  11. RET 1 item
  12. Bromodomain-containing proteins(BRDs) 1 item
  13. MEK 1 item
  14. FGFR 1 item
  15. Src 3item
  16. Microtubules/Tubulins 1 item
  17. ROCK 5item
  18. JAK 1 item
  19. DNA-PK 1 item
  20. Ksp 1 item
  21. PKC 1 item
  22. RAD51 1 item
  23. LRRK2 1 item
  24. PKG 1 item
  25. PKA 1 item
  26. Myosin light chain kinases (MLCKs) 1 item
  27. MK2 1 item
  28. ATM/ATR 4item
  29. Cdc42 1 item
  30. Hck 1 item
  31. Cdc7 1 item
  32. Ubiquitin-activating Enzyme E1 1 item
  33. Microtubule/Tubulin 1 item
  34. VEGFR3/FLT4 1 item
  35. NTRK1/TRKA 1 item
  36. CSF-1R/c-Fms 1 item
  37. nuclear export 1 item
  38. CRM1 1 item
  39. Hec1 1 item
  40. Histone Acetyltransferases (HATs) 1 item
  41. Rho 1 item
  42. Lck 1 item
  43. FGR 1 item
  44. YES 1 item
  45. Fyn 1 item
  46. ARG 1 item
  47. Rho-kinase 1 item
  48. PTEN 1 item
Related Disease
  1. Acute Myeloid Leukemia 3item
  2. B-lymphoid Malignancies 1 item
  3. Breast Cancer 4item
  4. Cancer 45item
  5. Cervical Cancer 1 item
  6. Chronic Lymphocytic Leukemia 2item
  7. Colon Cancer 3item
  8. Colon Carcinoma 1 item
  9. Colorectal Cancer 3item
  10. Glioma 2item
  11. Leukemia 1 item
  12. Lung Cancer 2item
  13. Lymphoma 2item
  14. Mantle Cell Lymphoma 1 item
  15. Melanoma 1 item
  16. Multiple Myeloma 1 item
  17. Ovarian Cancer 3item
  18. Pancreatic Cancer 3item
  19. Prostate Cancer 2item
  20. Renal Cell Carcinoma 1 item
  21. Thyroid Cancer 1 item